Return On Equity in % of Cytek Biosciences, Inc. from 2020 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cytek Biosciences, Inc. quarterly/annual Return On Equity history and change rate from 2020 to 2024.
  • Cytek Biosciences, Inc. Return On Equity for the quarter ending 30 Jun 2023 was -1.39 %, a 116% decline year-over-year.
  • Cytek Biosciences, Inc. annual Return On Equity for 2024 was -1.54 %, a 47.4% increase from 2023.
  • Cytek Biosciences, Inc. annual Return On Equity for 2023 was -2.93 %, a 590% decline from 2022.
  • Cytek Biosciences, Inc. annual Return On Equity for 2022 was 0.6 %, a 61.4% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Cytek Biosciences, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2023 -1.39 -0.74 -116% 01 Apr 2023 30 Jun 2023
Q1 2023 -0.52 -0.77 -302% 01 Jan 2023 31 Mar 2023
Q4 2022 0.6 -0.95 -61.4% 01 Oct 2022 31 Dec 2022
Q3 2022 -0.58 -11.4 -105% 01 Jul 2022 30 Sep 2022
Q2 2022 -0.64 +85.6 +99.3% 01 Apr 2022 30 Jun 2022
Q1 2022 0.25 +88.3 01 Jan 2022 31 Mar 2022
Q4 2021 1.55 +66.1 01 Oct 2021 31 Dec 2021
Q3 2021 10.8 01 Jul 2021 30 Sep 2021
Q2 2021 -86.2 01 Apr 2021 30 Jun 2021
Q1 2021 -88 01 Jan 2021 31 Mar 2021
Q4 2020 -64.6 01 Oct 2020 31 Dec 2020

Cytek Biosciences, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -1.54 +1.39 +47.4% 01 Jan 2024 31 Dec 2024
2023 -2.93 -3.53 -590% 01 Jan 2023 31 Dec 2023
2022 0.6 -0.95 -61.4% 01 Jan 2022 31 Dec 2022
2021 1.55 +66.1 01 Jan 2021 31 Dec 2021
2020 -64.6 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.